Rheumatoid Arthritis of the Craniovertebral Junction: Surgical Strategies, Current Approach and Proposal of a New Therapeutic Algorithm
Journal Title: Journal of Rheumatic Diseases and Treatment - Year 2017, Vol 3, Issue 2
Abstract
Rheumatoid Arthritis (RA) is a systemic inflammatory disease with an autoimmune feature and an etiology that is still unknown. It is characterized by a symmetrical peripheral polyarthritis that affects primarily the small joints of hands and feet, with several levels of extra-articular manifestation.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP348836
- DOI 10.23937/2469-5726/1510052
- Views 104
- Downloads 0
HLA-DR Frequency in Individuals with Rheumatoid Arthritis and Lung Affection
Objective: Establishing the frequency of HLA-DR antigens in a group of individuals with rheumatoid arthritis (RA) and investigate the correlation of such antigens with pulmonary involvement. Participants and methods: Th...
Relapsing Polychondritis
Relapsing polychondritis (RP) is a rare immune-mediated disease that may affect multiple organs. It is characterised by recurrent episodes of inflammation of cartilaginous structures and other connective tissues, rich in...
Glucocorticoid-Induced Leucine Zipper (Gilz) in Rheumatoid Arthritis: Relationship with Disease Activity and Steroid Use
Aims: Approximately 50% of rheumatoid arthritis (RA) patients require treatment with glucocorticoids (GC) to control inflammation [1]. Although effective, GC cause numerous adverse effects. Glucocorticoid-induced leucine...
SLE - Update Ethiopathogenesis Leading to Biological Therapy
Systemic lupus erythematosus is a chronic, autoimmune disorder which may have even fatal consequences, particularly if it affects vital organs of the human body. It is typically manifested by inflammation of various orga...
Meta-Analysis of the Clinical Efficacy of the Placebo Effect from Tumour-Necrosis-Factor Inhibitors to Treat Rheumatoid Arthritis after Methotrexate Failure
Introduction: Tumour-necrosis-factor (TNF) inhibitors, used to treat rheumatoid arthritis (RA), have non-specific (placebo effect) and specific effects. This meta-analysis appraises these effects within the first 3 month...